AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 163 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.65 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $311,000 | +31.2% | 23,006 | +86.9% | 0.08% | +143.8% |
Q3 2019 | $237,000 | -66.9% | 12,309 | -49.2% | 0.03% | -60.0% |
Q2 2019 | $715,000 | +93.8% | 24,209 | +303.5% | 0.08% | +300.0% |
Q3 2018 | $369,000 | -62.3% | 6,000 | -63.4% | 0.02% | -66.7% |
Q4 2017 | $980,000 | +213.1% | 16,400 | +154.5% | 0.06% | +185.7% |
Q3 2017 | $313,000 | +21.3% | 6,444 | +31.3% | 0.02% | +23.5% |
Q2 2017 | $258,000 | +17.8% | 4,906 | -60.6% | 0.02% | +41.7% |
Q2 2016 | $219,000 | -70.1% | 12,437 | -69.8% | 0.01% | -66.7% |
Q3 2015 | $732,000 | – | 41,248 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |